Table 2.
TP | FP | FN | Annotations | Precision | Recall | F1-score | |
Uveitis | 277 | 1 | 1 | 278 | 0.996 | 0.996 | 0.996 |
Dactylitis | 94 | 3 | 2 | 96 | 0.969 | 0.979 | 0.974 |
SpA | 147 | 5 | 3 | 150 | 0.967 | 0.980 | 0.974 |
Enthesitis | 392 | 2 | 38 | 430 | 0.995 | 0.912 | 0.951 |
AxSpA | 16 | 1 | 1 | 17 | 0.941 | 0.941 | 0.941 |
AS | 73 | 20 | 4 | 77 | 0.785 | 0.948 | 0.859 |
pSpA | 4 | 0 | 2 | 6 | 1.000 | 0.667 | 0.800 |
Infliximab | 11 | 0 | 0 | 11 | 1.000 | 1.000 | 1.000 |
Etanercept | 32 | 1 | 1 | 33 | 0.970 | 0.970 | 0.970 |
Adalimumab | 46 | 3 | 0 | 46 | 0.939 | 1.000 | 0.968 |
AS, ankylosing spondylitis (currently r-axSpA); axSpA, axial SpA; FN, false negative; FP, false positive; pSpA, peripheral SpA; SpA, spondyloarthritis; TP, true positive.